Metabolic Reprogramming of Cancer-Associated Fibroblast in the Tumor Microenvironment: From Basics to Clinic
Open Access
- 1 January 2024
- journal article
- review article
- Published by SAGE Publications in Clinical Medicine Insights: Oncology
- Vol. 18
Abstract
Metabolic reprogramming occurs when tumor cells replenish themselves with nutrients required for growth to meet their metabolic needs. Cancer-associated fibroblasts (CAFs) are activated fibroblasts involved in building the c (TME) to promote tumor progression and metastasis. Metabolic reprogramming of CAFs can interact with cancer cells to generate metabolic crosstalk. Furthermore, CAF metabolic reprogramming has great potential as a new field of tumor treatment. This review summarizes the role of CAFs in TME and the mechanisms by which metabolic reprogramming of CAFs causes cancer progression and metastasis, demonstrating the great potential of CAF metabolic reprogramming in cancer chemotherapy and immunotherapy treatment. Furthermore, we provide an outlook for future CAF metabolic reprogramming for cancer treatment.Keywords
This publication has 82 references indexed in Scilit:
- Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal CellsCancer Research, 2015
- Translational Implications of Tumor HeterogeneityClinical Cancer Research, 2015
- Hexokinase 2 regulates G1/S checkpoint through CDK2 in cancer-associated fibroblastsCellular Signalling, 2014
- Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cellsOncotarget, 2014
- Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progressionBreast Cancer Research, 2014
- Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapyCancer and Metastasis Reviews, 2014
- miR-186 Regulates Glycolysis through Glut1 During the Formation of Cancer-associated FibroblastsAsian Pacific Journal of Cancer Prevention, 2014
- Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vesselsNature Communications, 2013
- Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblastsNature Cell Biology, 2013
- Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and MechanismsAnnual Review of Pathology: Mechanisms of Disease, 2012